Adverse Outcomes After Initial Non-surgical Management of Subdural Hematoma: A Population-Based Study

Neurocritical Care

Volumn 24, Issue 2, 2016, Pages 226-232

  Morris, Nicholas A ^a,b   Merkler, Alexander E ^a,b   Parker, Whitney E ^b   Claassen, Jan ^a   Connolly, E Sander ^a   Sheth, Kevin N ^c   Kamel, Hooman ^b,d  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

Author keywords

Nonsurgical management; Nontraumatic subdural hematoma; Readmission rates; Subdural hematoma; Trauma

Indexed keywords

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COHORT ANALYSIS; COMORBIDITY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBDURAL HEMATOMA; THROMBOCYTE FUNCTION; UNITED STATES; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM; CALIFORNIA; DISEASE MANAGEMENT; FLORIDA; FOLLOW UP; HEMATOMA, SUBDURAL; HOSPITAL MORTALITY; MIDDLE AGED; NEW YORK; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CALIFORNIA; DISEASE MANAGEMENT; FEMALE; FLORIDA; FOLLOW-UP STUDIES; HEMATOMA, SUBDURAL; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NEW YORK; PATIENT READMISSION; RETROSPECTIVE STUDIES;

EID: 84962407126     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-015-0178-x     Document Type: Article

References (21)

1. Frontera JA, Egorova N, Moskowitz AJ. National trend in prevalence, cost, and discharge disposition after subdural hematoma from 1998-2007. Crit Care Med. 2011;39(7):1619–25.
2. U.S. Census Bureau. Census QuickFacts. http://quickfacts.census.gov. Accessed March 10 2015.
3. Wysowski DK, Nourjah P, Swartz L. Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action. Arch Intern Med. 2007;167(13):1414–9.
4. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120(11):897–902.
5. Agency for Healthcare Research and Quality. Healthcare Cost and Utilization Project. http://hcupnet.ahrq.gov. Accessed March 10 2015.
6. Bullock MR, Chesnut R, Ghajar J, et al. Surgical management of acute subdural hematomas. Neurosurgery. 2006;58(3 Suppl):S16–24; discussion Si–iv.
7. Wong CW. Criteria for conservative treatment of supratentorial acute subdural haematomas. Acta Neurochir (Wien). 1995;135(1–2):38–43.
8. Dent DL, Croce MA, Menke PG, et al. Prognostic factors after acute subdural hematoma. J Trauma. 1995;39(1):36–42;discussion 42–33.
9. Croce MA, Dent DL, Menke PG, et al. Acute subdural hematoma: nonsurgical management of selected patients. J Trauma. 1994;36(6):820–6; discussion 826–827.
10. Mathew P, Oluoch-Olunya DL, Condon BR, Bullock R. Acute subdural haematoma in the conscious patient: outcome with initial non-operative management. Acta Neurochir (Wien). 1993;121(3–4):100–8.
11. Servadei F, Nasi MT, Cremonini AM, Giuliani G, Cenni P, Nanni A. Importance of a reliable admission Glasgow Coma Scale score for determining the need for evacuation of posttraumatic subdural hematomas: a prospective study of 65 patients. J Trauma. 1998;44(5):868–73.
12. Feliciano CE, De Jesus O. Conservative management outcomes of traumatic acute subdural hematomas. P R Health Sci J. 2008;27(3):220–3.
13. Seifi A, Asadi-Pooya AA, Carr K, et al. The epidemiology, risk factors, and impact on hospital mortality of status epilepticus after subdural hematomas in the United States. SpringerPlus. 2014;3:332.
14. Agency for Healthcare Research and Quality. HCUP methods series: methodological issues when studying readmissions and revisits using hospital administrative data. http://www.hcup-us.ahrq.gov/reports/methods/2011_01.pdf. Accessed March 10 2015.
15. De Coster C, Li B, Quan H. Comparison and validity of procedures coded With ICD-9-CM and ICD-10-CA/CCI. Med Care. 2008;46(6):627–34.
16. Son S, Yoo CJ, Lee SG, Kim EY, Park CW, Kim WK. Natural course of initially non-operated cases of acute subdural hematoma: the risk factors of hematoma progression. J Korean Neurosurg Soc. 2013;54(3):211–9.
17. Kim BJ, Park KJ, Park DH, et al. Risk factors of delayed surgical evacuation for initially nonoperative acute subdural hematomas following mild head injury. Acta Neurochir (Wien). 2014;156(8):1605–13.
18. Laviv Y, Rappaport ZH. Risk factors for development of significant chronic subdural hematoma following conservative treatment of acute subdural hemorrhage. Br J Neurosurg. 2014;28(6):733–8.
19. Agency for Healthcare Research and Quality. Clinical classification software for ICD-9-CM. http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed March 10 2015.
20. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.
21. Coombs JB, Coombs BL, Chin EJ. Acute spontaneous subdural hematoma in a middle-aged adult: case report and review of the literature. J Emerg Med. 2014;47(3):e63–8.